Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention

By sjmartinez • January 14, 2023

Nicholas SB, Cervantes L; Clinical Care & Innovation Workgroup of the American Society of Nephrology Health Care Justice Committee. Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention. J Am Soc Nephrol. 2022 Sep;33(9):1652-1655. doi: 10.1681/ASN.2022040427. Epub 2022 Jun 29. PMID: 35768179; PMCID: PMC9529187.

Tags: Chronic kidney disease, Clinical Trial, community engagement, Diversity, Nephrology, patient partners, Publications, racial and ethnic disparities

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Heerspink HJL, Beernink JM, Agarwal R, Cherney DZI, Lam CSP, Neuen BL, Perkovic V, Tuttle KR, Sarafidis P, Birne R, Chen X, Hornum M, Maldonado[...]

Correction of Alkalemia in a Hemodialysis Patient: A Case Report

Luu YH, Hajmomenian HR, Khorsan R. Correction of Alkalemia in a Hemodialysis Patient: A Case Report. Cureus. 2026 Jul 28;18(7):e113556. doi: 10.7759/cureus.113556. PMID: 42666655; PMCID:[...]

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]